{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:31:53Z","timestamp":1792099913947,"version":"4.4.0"},"reference-count":64,"publisher":"American Veterinary Medical Association (AVMA)","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ajvr"],"published-print":{"date-parts":[[2025,4,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:p>Canine cognitive dysfunction (CCD) is a common neurodegenerative disorder among geriatric dogs, characterized by disorientation, interaction changes, sleep-wake cycle disturbances, house soiling, activity level changes, and anxiety. Canine cognitive dysfunction is currently underdiagnosed due to the lack of an objective and reliable diagnostic tool, and treatment options are severely limited. Importantly, CCD shares common pathological hallmarks of human Alzheimer disease, such as \u03b2-amyloid accumulation, \u03c4 protein phosphorylation, neuronal loss, and neuroinflammation. \u03b2-Amyloid deposits in Alzheimer disease and CCD appear in 2 main forms: extracellular amyloid plaques, which disrupt synaptic function and contribute to neurotoxicity, and cerebral amyloid angiopathy, where \u03b2-amyloid accumulates in the walls of cerebral blood vessels. Cerebral amyloid angiopathy leads to vascular dysfunction, chronic hypoxia, microhemorrhages, and neuroinflammation, further exacerbating cognitive decline. Research into these shared pathologies offers potential therapeutic targets that could benefit both canine and human patients suffering from these neurodegenerative disorders. In this article, we review the latest understanding of CCD pathology and discuss new advancements in diagnostic and therapeutic options as well as the outlook of the CCD disorder.<\/jats:p>","DOI":"10.2460\/ajvr.25.02.0053","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T13:09:02Z","timestamp":1745932142000},"page":"1-8","source":"Crossref","is-referenced-by-count":12,"title":["Recent advances in diagnostic and therapeutic strategies for canine cognitive dysfunction"],"prefix":"10.2460","author":[{"given":"Sang Hyun","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Foundational Sciences, College of Veterinary Medicine, Western University of Health Sciences, Pomona, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6769-9069","authenticated-orcid":true,"given":"Jijun","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Foundational Sciences, College of Veterinary Medicine, Western University of Health Sciences, Pomona, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1272","reference":[{"key":"B1","series-title":"Front Vet Sci","first-page":"958488","article-title":"Assessment of risk factors in dogs with presumptive advanced canine cognitive dysfunction","volume":"9","author":"MacQuiddy B","year":"2022","unstructured":"MacQuiddy B, Moreno JA, Kusick B, McGrath S. Assessment of risk factors in dogs with presumptive advanced canine cognitive dysfunction. Front Vet Sci. 2022;9:958488. doi:10.3389\/fvets.2022.958488"},{"issue":"4","key":"B2","series-title":"Vet Clin North Am Small Anim Pract","first-page":"749","article-title":"Cognitive dysfunction syndrome: a disease of canine and feline brain aging","volume":"42","author":"Landsberg GM","year":"2012","unstructured":"Landsberg GM, Nichol J, Araujo JA. Cognitive dysfunction syndrome: a disease of canine and feline brain aging. Vet Clin North Am Small Anim Pract. 2012;42(4):749\u2013768. doi:10.1016\/j.cvsm.2012.04.003"},{"issue":"12","key":"B3","series-title":"J Vet Med Sci","first-page":"1829","article-title":"Physical signs of canine cognitive dysfunction","volume":"81","author":"Ozawa M","year":"2019","unstructured":"Ozawa M, Inoue M, Uchida K, Chambers JK, Takeuch Y, Nakayama H. Physical signs of canine cognitive dysfunction. J Vet Med Sci. 2019;81(12):1829\u20131834. doi:10.1292\/jvms.19-0458"},{"issue":"3","key":"B4","series-title":"Vet J","first-page":"277","article-title":"Under diagnosis of canine cognitive dysfunction: a cross-sectional survey of older companion dogs","volume":"184","author":"Salvin HE","year":"2010","unstructured":"Salvin HE, McGreevy PD, Sachdev PS, Valenzuela MJ. Under diagnosis of canine cognitive dysfunction: a cross-sectional survey of older companion dogs. Vet J. 2010;184(3):277\u2013281. doi:10.1016\/j.tvjl.2009.11.007"},{"issue":"11","key":"B5","series-title":"J Am Vet Med Assoc","first-page":"1597","article-title":"Canine cognitive decline and Alzheimer disease: clinical insights to solve a shared one-health problem","volume":"261","author":"Ehrenzweig J","year":"2023","unstructured":"Ehrenzweig J, Hunter RP. Canine cognitive decline and Alzheimer disease: clinical insights to solve a shared one-health problem. J Am Vet Med Assoc. 2023;261(11):1597\u20131604. doi:10.2460\/javma.23.02.0095"},{"key":"B6","series-title":"Front Neurosci","first-page":"604","article-title":"Canine cognitive dysfunction and Alzheimer\u2019s disease - two facets of the same disease?","volume":"13","author":"Prpar Mihevc S","year":"2019","unstructured":"Prpar Mihevc S, Majdic G. Canine cognitive dysfunction and Alzheimer\u2019s disease - two facets of the same disease? Front Neurosci. 2019;13:604. doi:10.3389\/fnins.2019.00604"},{"issue":"1","key":"B7","series-title":"Neurotherapeutics","first-page":"3","article-title":"Beta-amyloid peptides and amyloid plaques in Alzheimer\u2019s disease","volume":"12","author":"Gouras GK","year":"2015","unstructured":"Gouras GK, Olsson TT, Hansson O. Beta-amyloid peptides and amyloid plaques in Alzheimer\u2019s disease. Neurotherapeutics. 2015;12(1):3\u201311. doi:10.1007\/s13311-014-0313-y"},{"issue":"17","key":"B8","series-title":"Cells","first-page":"2728","article-title":"Role of microglia and astrocytes in Alzheimer\u2019s disease: from neuroinflammation to ca2+ homeostasis dysregulation","volume":"11","author":"Di Benedetto G","year":"2022","unstructured":"Di Benedetto G, Burgaletto C, Bellanca CM, Munaf\u00f2 A, Bernardini R, Cantarella G. Role of microglia and astrocytes in Alzheimer\u2019s disease: from neuroinflammation to ca2+ homeostasis dysregulation. Cells. 2022;11(17):2728. doi:10.3390\/cells11172728"},{"issue":"1","key":"B9","series-title":"Neurobiol Learn Mem","first-page":"11","article-title":"Beta-amyloid accumulation correlates with cognitive dysfunction in the aged canine","volume":"66","author":"Cummings BJ","year":"1996","unstructured":"Cummings BJ, Head E, Afagh AJ, Milgram NW, Cotman CW. Beta-amyloid accumulation correlates with cognitive dysfunction in the aged canine. Neurobiol Learn Mem. 1996;66(1):11\u201323. doi:10.1006\/nlme.1996.0039"},{"issue":"5","key":"B10","series-title":"Geroscience","first-page":"2379","article-title":"Canine cognitive dysfunction (CCD) scores correlate with amyloid beta 42 levels in dog brain tissue","volume":"43","author":"Urfer SR","year":"2021","unstructured":"Urfer SR, Darvas M, Czeibert K, et al. Canine cognitive dysfunction (CCD) scores correlate with amyloid beta 42 levels in dog brain tissue. Geroscience. 2021;43(5):2379\u20132386. doi:10.1007\/s11357-021-00422-1"},{"issue":"9","key":"B11","series-title":"J Neuropathol Exp Neurol","first-page":"912","article-title":"Detection and quantification of \u03b2-amyloid, pyroglutamyl A\u03b2, and tau in aged canines","volume":"74","author":"Schmidt F","year":"2015","unstructured":"Schmidt F, Boltze J, J\u00e4ger C, et al. Detection and quantification of \u03b2-amyloid, pyroglutamyl A\u03b2, and tau in aged canines. J Neuropathol Exp Neurol. 2015;74(9):912\u2013923. doi:10.1097\/NEN.0000000000000230"},{"issue":"6","key":"B12","series-title":"J Vet Med Sci","first-page":"997","article-title":"The relation between canine cognitive dysfunction and age-related brain lesions","volume":"78","author":"Ozawa M","year":"2016","unstructured":"Ozawa M, Chambers JK, Uchida K, Nakayama H. The relation between canine cognitive dysfunction and age-related brain lesions. J Vet Med Sci. 2016;78(6):997\u20131006. doi:10.1292\/jvms.15-0624"},{"issue":"1","key":"B13","series-title":"J Alzheimers Dis Rep","first-page":"749","article-title":"Neuronal deposition of amyloid-\u03b2 oligomers and hyperphosphorylated tau is closely connected with cognitive dysfunction in aged dogs","volume":"5","author":"Habiba U","year":"2021","unstructured":"Habiba U, Ozawa M, Chambers JK, et al. Neuronal deposition of amyloid-\u03b2 oligomers and hyperphosphorylated tau is closely connected with cognitive dysfunction in aged dogs. J Alzheimers Dis Rep. 2021;5(1):749\u2013760. doi:10.3233\/ADR-210035"},{"issue":"1","key":"B14","series-title":"Indian J Psychiatry","first-page":"55","article-title":"Neurobiology of Alzheimer\u2019s disease","volume":"51","author":"Mohandas E","year":"2009","unstructured":"Mohandas E, Rajmohan V, Raghunath B. Neurobiology of Alzheimer\u2019s disease. Indian J Psychiatry. 2009;51(1):55\u201361. doi:10.4103\/0019-5545.44908"},{"issue":"1","key":"B15","series-title":"Brain Pathol","first-page":"144","article-title":"Distribution of tau hyperphosphorylation in canine dementia resembles early Alzheimer\u2019s disease and other tauopathies","volume":"31","author":"Abey A","year":"2021","unstructured":"Abey A, Davies D, Goldsbury C, Buckland M, Valenzuela M, Duncan T. Distribution of tau hyperphosphorylation in canine dementia resembles early Alzheimer\u2019s disease and other tauopathies. Brain Pathol. 2021;31(1):144\u2013162. doi:10.1111\/bpa.12893"},{"key":"B16","series-title":"Front Aging Neurosci","first-page":"1128521","article-title":"Activated gliosis, accumulation of amyloid \u03b2, and hyperphosphorylation of tau in aging canines with and without cognitive decline","volume":"15","author":"Hines AD","year":"2023","unstructured":"Hines AD, McGrath S, Latham AS, et al. Activated gliosis, accumulation of amyloid \u03b2, and hyperphosphorylation of tau in aging canines with and without cognitive decline. Front Aging Neurosci. 2023;15:1128521. doi:10.3389\/fnagi.2023.1128521"},{"key":"B17","series-title":"Front Vet Sci","first-page":"573155","article-title":"Nitrosative stress in the frontal cortex from dogs with canine cognitive dysfunction","volume":"7","author":"Prpar Mihevc S","year":"2020","unstructured":"Prpar Mihevc S, Zakosek Pipan M, Strbenc M, Rogelj B, Majdic G. Nitrosative stress in the frontal cortex from dogs with canine cognitive dysfunction. Front Vet Sci. 2020;7:573155. doi:10.3389\/fvets.2020.573155"},{"key":"B18","series-title":"Front Aging Neurosci","first-page":"7","article-title":"An aged canid with behavioral deficits exhibits blood and cerebrospinal fluid amyloid beta oligomers","volume":"10","author":"Rusbridge C","year":"2018","unstructured":"Rusbridge C, Salguero FJ, David MA, et al. An aged canid with behavioral deficits exhibits blood and cerebrospinal fluid amyloid beta oligomers. Front Aging Neurosci. 2018;10:7. doi:10.3389\/fnagi.2018.00007"},{"issue":"2","key":"B19","series-title":"3 Biotech","first-page":"55","article-title":"Hippocampus and its involvement in Alzheimer\u2019s disease: a review","volume":"12","author":"Rao YL","year":"2022","unstructured":"Rao YL, Ganaraja B, Murlimanju BV, Joy T, Krishnamurthy A, Agrawal A. Hippocampus and its involvement in Alzheimer\u2019s disease: a review. 3 Biotech. 2022;12(2):55. doi:10.1007\/s13205-022-03123-4"},{"issue":"4","key":"B20","series-title":"Open Vet J","first-page":"438","article-title":"Canine cognitive dysfunction patients have reduced total hippocampal volume compared with aging control dogs: a comparative magnetic resonance imaging study","volume":"10","author":"Dewey CW","year":"2021","unstructured":"Dewey CW, Rishniw M, Johnson PJ, et al. Canine cognitive dysfunction patients have reduced total hippocampal volume compared with aging control dogs: a comparative magnetic resonance imaging study. Open Vet J. 2021;10(4):438\u2013442. doi:10.4314\/ovj.v10i4.11"},{"issue":"17","key":"B21","series-title":"Neurology","first-page":"e1647","article-title":"High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis","volume":"93","author":"Schindler SE","year":"2019","unstructured":"Schindler SE, Bollinger JG, Ovod V, et al. High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis. Neurology. 2019;93(17):e1647\u2013e1659. doi:10.1212\/WNL.0000000000008081"},{"issue":"2","key":"B22","series-title":"Mol Neurobiol","first-page":"483","article-title":"Plasma amyloid beta concentrations in aged and cognitively impaired pet dogs","volume":"58","author":"Panek WK","year":"2021","unstructured":"Panek WK, Murdoch DM, Gruen ME, Mowat FM, Marek RD, Olby NJ. Plasma amyloid beta concentrations in aged and cognitively impaired pet dogs. Mol Neurobiol. 2021;58(2):483\u2013489. doi:10.1007\/s12035-020-02140-9"},{"issue":"1","key":"B23","series-title":"BMC Vet Res","first-page":"60","article-title":"Change in the plasma proteome associated with canine cognitive dysfunction syndrome (CCDS) in Thailand","volume":"17","author":"Phochantachinda S","year":"2021","unstructured":"Phochantachinda S, Chantong B, Reamtong O, Chatchaisak D. Change in the plasma proteome associated with canine cognitive dysfunction syndrome (CCDS) in Thailand. BMC Vet Res. 2021;17(1):60. doi:10.1186\/s12917-021-02744-w"},{"issue":"6","key":"B24","series-title":"J Vet Intern Med","first-page":"1569","article-title":"Cognitive function, progression of age-related behavioral changes, biomarkers, and survival in dogs more than 8 years old","volume":"29","author":"Sch\u00fctt T","year":"2015","unstructured":"Sch\u00fctt T, Toft N, Berendt M. Cognitive function, progression of age-related behavioral changes, biomarkers, and survival in dogs more than 8 years old. J Vet Intern Med. 2015;29(6):1569\u20131577. doi:10.1111\/jvim.13633"},{"issue":"4","key":"B25","series-title":"J Vet Intern Medv","first-page":"1532","article-title":"Amyloid-beta plasma and cerebrospinal fluid biomarkers in aged dogs with cognitive dysfunction syndrome","volume":"34","author":"Stylianaki I","year":"2020","unstructured":"Stylianaki I, Polizopoulou ZS, Theodoridis A, Koutouzidou G, Baka R, Papaioannou NG. Amyloid-beta plasma and cerebrospinal fluid biomarkers in aged dogs with cognitive dysfunction syndrome. J Vet Intern Medv 2020;34(4):1532\u20131540. doi:10.1111\/jvim.15812"},{"key":"B26","series-title":"Front Vet Sci","first-page":"551895","article-title":"Novel diagnostic tools for identifying cognitive impairment in dogs: behavior, biomarkers, and pathology","volume":"7","author":"Vikartovska Z","year":"2020","unstructured":"Vikartovska Z, Farbakova J, Smolek T, et al. Novel diagnostic tools for identifying cognitive impairment in dogs: behavior, biomarkers, and pathology. Front Vet Sci. 2020;7:551895. doi:10.3389\/fvets.2020.551895"},{"issue":"6","key":"B27","series-title":"Zool Res","first-page":"1026","article-title":"Animal models of Alzheimer\u2019s disease: applications, evaluation, and perspectives","volume":"43","author":"Chen ZY","year":"2022","unstructured":"Chen ZY, Zhang Y. Animal models of Alzheimer\u2019s disease: applications, evaluation, and perspectives. Zool Res. 2022;43(6):1026\u20131040. doi:10.24272\/j.issn.2095-8137.2022.289"},{"issue":"3","key":"B28","series-title":"Vet Clin North Am Small Anim Pract","first-page":"477","article-title":"Canine cognitive dysfunction: pathophysiology, diagnosis, and treatment","volume":"49","author":"Dewey CW","year":"2019","unstructured":"Dewey CW, Davies ES, Xie H, Wakshlag JJ. Canine cognitive dysfunction: pathophysiology, diagnosis, and treatment. Vet Clin North Am Small Anim Pract. 2019;49(3):477\u2013499. doi:10.1016\/j.cvsm.2019.01.013"},{"issue":"1","key":"B29","series-title":"Free Radic Biol Med","first-page":"134","article-title":"Oxidative stress hypothesis in Alzheimer\u2019s disease","volume":"23","author":"Markesbery WR","year":"1997","unstructured":"Markesbery WR. Oxidative stress hypothesis in Alzheimer\u2019s disease. Free Radic Biol Med. 1997;23(1):134\u2013147. doi:10.1016\/s0891-5849(96)00629-6"},{"issue":"1","key":"B30","series-title":"Cent Nerv Syst Agents Med Chem","first-page":"16","article-title":"A dual activity of ROS and oxidative stress on adult neurogenesis and Alzheimer\u2019s disease","volume":"10","author":"Taupin P","year":"2010","unstructured":"Taupin P. A dual activity of ROS and oxidative stress on adult neurogenesis and Alzheimer\u2019s disease. Cent Nerv Syst Agents Med Chem. 2010;10(1):16\u201321. doi:10.2174\/187152410790780172"},{"issue":"5","key":"B31","series-title":"Neurobiol Aging","first-page":"809","article-title":"Brain aging in the canine: a diet enriched in antioxidants reduces cognitive dysfunction","volume":"23","author":"Cotman CW","year":"2002","unstructured":"Cotman CW, Head E, Muggenburg BA, Zicker S, Milgram NW. Brain aging in the canine: a diet enriched in antioxidants reduces cognitive dysfunction. Neurobiol Aging. 2002;23(5):809\u2013818. doi:10.1016\/s0197-4580(02)00073-8"},{"key":"B32","series-title":"Neurochem Int","first-page":"51","article-title":"Essential role of docosahexaenoic acid towards development of a smarter brain","volume":"89","author":"Gharami K","year":"2015","unstructured":"Gharami K, Das M, Das S. Essential role of docosahexaenoic acid towards development of a smarter brain. Neurochem Int. 2015;89:51\u201362. doi:10.1016\/j.neuint.2015.08.014"},{"issue":"17","key":"B33","series-title":"JAMA","first-page":"1903","article-title":"Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial","volume":"304","author":"Quinn JF","year":"2010","unstructured":"Quinn JF, Raman R, Thomas RG, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA. 2010;304(17):1903\u20131911. doi:10.1001\/jama.2010.1510"},{"key":"B34","series-title":"Front Vet Sci","first-page":"646451","article-title":"Sphingolipids and DHA improve cognitive deficits in aged Beagle dogs","volume":"9","author":"Araujo JA","year":"2022","unstructured":"Araujo JA, Segarra S, Mendes J, et al. Sphingolipids and DHA improve cognitive deficits in aged Beagle dogs. Front Vet Sci. 2022;9:646451. doi:10.3389\/fvets.2022.646451"},{"issue":"2","key":"B35","series-title":"J Alzheimers Dis","first-page":"637","article-title":"Amyloid-beta peptide and oligomers in the brain and cerebrospinal fluid of aged canines","volume":"20","author":"Head E","year":"2010","unstructured":"Head E, Pop V, Sarsoza F, et al. Amyloid-beta peptide and oligomers in the brain and cerebrospinal fluid of aged canines. J Alzheimers Dis. 2010;20(2):637\u2013646. doi:10.3233\/JAD-2010-1397"},{"issue":"5","key":"B36","series-title":"Indian J Med Res","first-page":"471","article-title":"Involvement of nitric oxide in learning & memory processes","volume":"133","author":"Paul V","year":"2011","unstructured":"Paul V, Ekambaram P. Involvement of nitric oxide in learning & memory processes. Indian J Med Res. 2011;133(5):471\u2013478."},{"issue":"4","key":"B37","series-title":"Med Sci (Basel)","first-page":"72","article-title":"Nutrients, cognitive function, and brain aging: what we have learned from dogs","volume":"9","author":"Pan Y","year":"2021","unstructured":"Pan Y. Nutrients, cognitive function, and brain aging: what we have learned from dogs. Med Sci (Basel). 2021;9(4):72. doi:10.3390\/medsci9040072"},{"issue":"3","key":"B38","series-title":"Brit J Nutr","first-page":"349","article-title":"Cognitive enhancement in old dogs from dietary supplementation with a nutrient blend containing arginine, antioxidants, B vitamins and fish oil","volume":"119","author":"Pan YL","year":"2018","unstructured":"Pan YL, Kennedy AD, J\u00f6nsson TJ, Milgram NW. Cognitive enhancement in old dogs from dietary supplementation with a nutrient blend containing arginine, antioxidants, B vitamins and fish oil. Brit J Nutr. 2018;119(3):349\u2013358. doi:10.1017\/S0007114517003464"},{"issue":"2","key":"B39","series-title":"Psychiatry Res","first-page":"147","article-title":"Reduced cerebral glucose metabolism in patients at risk for Alzheimer\u2019s disease","volume":"155","author":"Hunt A","year":"2007","unstructured":"Hunt A, Sch\u00f6nknecht P, Henze M, Seidl U, Haberkorn U, Schr\u00f6der J. Reduced cerebral glucose metabolism in patients at risk for Alzheimer\u2019s disease. Psychiatry Res. 2007;155(2):147\u2013154. doi:10.1016\/j.pscychresns.2006.12.003"},{"key":"B40","series-title":"Ageing Res Rev","first-page":"101001","article-title":"Medium chain triglycerides induce mild ketosis and may improve cognition in Alzheimer\u2019s disease: a systematic review and meta-analysis of human studies","volume":"58","author":"Avgerinos KI","year":"2020","unstructured":"Avgerinos KI, Egan JM, Mattson MP, Kapogiannis D. Medium chain triglycerides induce mild ketosis and may improve cognition in Alzheimer\u2019s disease: a systematic review and meta-analysis of human studies. Ageing Res Rev. 2020;58:101001. doi:10.1016\/j.arr.2019.101001"},{"issue":"12","key":"B41","series-title":"Brit J Nutr","first-page":"1746","article-title":"Dietary supplementation with medium-chain TAG has long-lasting cognition-enhancing effects in aged dogs","volume":"103","author":"Pan Y","year":"2010","unstructured":"Pan Y, Larson B, Araujo JA, et al. Dietary supplementation with medium-chain TAG has long-lasting cognition-enhancing effects in aged dogs. Brit J Nutr. 2010;103(12):1746\u20131754. doi:10.1017\/S0007114510000097"},{"key":"B42","series-title":"Front Nutr","first-page":"127","article-title":"Efficacy of a therapeutic diet on dogs with signs of cognitive dysfunction syndrome (CDS): a prospective double blinded placebo controlled clinical study","volume":"5","author":"Pan Y","year":"2018","unstructured":"Pan Y, Landsberg G, Mougeot I, et al. Efficacy of a therapeutic diet on dogs with signs of cognitive dysfunction syndrome (CDS): a prospective double blinded placebo controlled clinical study. Front Nutr. 2018;5:127. doi:10.3389\/fnut.2018.00127"},{"issue":"2","key":"B43","series-title":"Vet Ther","first-page":"69","article-title":"Effect of S-adenosylmethionine tablets on the reduction of age-related mental decline in dogs: a double-blinded, placebo-controlled trial","volume":"9","author":"R\u00e8me CA","year":"2008","unstructured":"R\u00e8me CA, Dramard V, Kern L, Hofmans J, Halsberghe C, Mombiela DV. Effect of S-adenosylmethionine tablets on the reduction of age-related mental decline in dogs: a double-blinded, placebo-controlled trial. Vet Ther. 2008;9(2):69\u201382."},{"issue":"1","key":"B44","series-title":"Vet Ther","first-page":"24","article-title":"A noncomparative open-label study evaluating the effect of selegiline hydrochloride in a clinical setting","volume":"2","author":"Campbell S","year":"2001","unstructured":"Campbell S, Trettien A, Kozan B. A noncomparative open-label study evaluating the effect of selegiline hydrochloride in a clinical setting. Vet Ther. 2001;2(1):24\u201339."},{"issue":"3","key":"B45","series-title":"Prog Neuropsychopharmacol Biol Psychiatry","first-page":"471","article-title":"Therapeutic agents for the treatment of cognitive dysfunction syndrome in senior dogs","volume":"29","author":"Landsberg G","year":"2005","unstructured":"Landsberg G. Therapeutic agents for the treatment of cognitive dysfunction syndrome in senior dogs. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(3):471\u2013479. doi:10.1016\/j.pnpbp.2004.12.012"},{"issue":"4","key":"B46","series-title":"Cochrane Database Syst Rev","first-page":"CD003159","article-title":"Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment","volume":"2001","author":"Fioravanti M","year":"2001","unstructured":"Fioravanti M, Flicker L. Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment. Cochrane Database Syst Rev. 2001;2001(4):CD003159. doi:10.1002\/14651858.CD003159"},{"issue":"5","key":"B47","series-title":"Mol Med Rep","first-page":"7293","article-title":"Ameliorative effect of nicergoline on cognitive function through the PI3K\/AKT signaling pathway in mouse models of Alzheimer\u2019s disease","volume":"17","author":"Zang GY","year":"2018","unstructured":"Zang GY, Fang LZ, Chen LY, Wang CY. Ameliorative effect of nicergoline on cognitive function through the PI3K\/AKT signaling pathway in mouse models of Alzheimer\u2019s disease. Mol Med Rep. 2018;17(5):7293\u20137300. doi:10.3892\/mmr.2018.8786"},{"key":"B48","series-title":"Small Animal Clinical Pharmacology","author":"Seksel K","year":"2008","unstructured":"Seksel K. Small Animal Clinical Pharmacology. 2nd ed. Elsevier Ltd; 2008."},{"issue":"1","key":"B49","series-title":"Sci Rep","first-page":"18098","article-title":"Treatment of canine cognitive dysfunction with novel butyrylcholinesterase inhibitor","volume":"11","author":"Zako\u0161ek Pipan M","year":"2021","unstructured":"Zako\u0161ek Pipan M, Prpar Mihevc S, \u0160trbenc M, et al. Treatment of canine cognitive dysfunction with novel butyrylcholinesterase inhibitor. Sci Rep. 2021;11(1):18098. doi:10.1038\/s41598-021-97404-2"},{"issue":"1","key":"B50","series-title":"Alzheimers Res Ther","first-page":"126","article-title":"Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer\u2019s disease: a network meta-analysis of 41 randomized controlled trials","volume":"10","author":"Dou KX","year":"2018","unstructured":"Dou KX, Tan MS, Tan CC, et al. Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer\u2019s disease: a network meta-analysis of 41 randomized controlled trials. Alzheimers Res Ther. 2018;10(1):126. doi:10.1186\/s13195-018-0457-9"},{"issue":"1","key":"B51","series-title":"J Alzheimers Dis","first-page":"143","article-title":"Cholinesterase inhibitors improve both memory and complex learning in aged Beagle dogs","volume":"26","author":"Araujo JA","year":"2011","unstructured":"Araujo JA, Greig NH, Ingram DK, Sandin J, de Rivera C, Milgram NW. Cholinesterase inhibitors improve both memory and complex learning in aged Beagle dogs. J Alzheimers Dis. 2011;26(1):143\u2013155. doi:10.3233\/JAD-2011-110005"},{"issue":"10","key":"B52","series-title":"Nat Med","first-page":"2409","article-title":"Senolytic therapy for Alzheimer\u2019s disease","volume":"29","author":"Longo FM","year":"2023","unstructured":"Longo FM, Massa SM. Senolytic therapy for Alzheimer\u2019s disease. Nat Med. 2023;29(10):2409\u20132411. doi:10.1038\/s41591-023-02541-y"},{"issue":"1","key":"B53","series-title":"Sci Rep","first-page":"12399","article-title":"A randomized, controlled clinical trial demonstrates improved owner-assessed cognitive function in senior dogs receiving a senolytic and NAD plus precursor combination","volume":"14","author":"Simon KE","year":"2024","unstructured":"Simon KE, Russell K, Mondino A, et al. A randomized, controlled clinical trial demonstrates improved owner-assessed cognitive function in senior dogs receiving a senolytic and NAD plus precursor combination. Sci Rep. 2024;14(1):12399. doi:10.1038\/s41598-024-63031-w"},{"issue":"10","key":"B54","series-title":"Int J Mol Sci","first-page":"9067","article-title":"Role of calcium modulation in the pathophysiology and treatment of Alzheimer\u2019s disease","volume":"24","author":"Baracaldo-Santamar\u00eda D","year":"2023","unstructured":"Baracaldo-Santamar\u00eda D, Avenda\u00f1o-Lopez SS, Ariza-Salamanca DF, et al. Role of calcium modulation in the pathophysiology and treatment of Alzheimer\u2019s disease. Int J Mol Sci. 2023;24(10):9067. doi:10.3390\/ijms24109067"},{"issue":"3","key":"B55","series-title":"J Vet Behav","first-page":"217","article-title":"A novel mechanism for cognitive enhancement in aged dogs with the use of a calcium-buffering protein","volume":"10","author":"Milgram NW","year":"2015","unstructured":"Milgram NW, Landsberg G, Merrick D, Underwood MY. A novel mechanism for cognitive enhancement in aged dogs with the use of a calcium-buffering protein. J Vet Behav. 2015;10(3):217\u2013222. doi:10.1016\/j.jveb.2015.02.003"},{"issue":"suppl 21","key":"B56","series-title":"Alzheimers Dement","first-page":"e078312","article-title":"Effect of calcineurin\/NFAT inhibitors on biomarkers and cognition in a canine model of Alzheimer disease","volume":"19","author":"Sordo L","year":"2023","unstructured":"Sordo L, Ubele MF, Boa K, et al. Effect of calcineurin\/NFAT inhibitors on biomarkers and cognition in a canine model of Alzheimer disease. Alzheimers Dement. 2023;19(suppl 21):e078312. doi:10.1002\/alz.078312"},{"issue":"1","key":"B57","series-title":"Stem Cell Res Ther","first-page":"261","article-title":"Autologous skin-derived neural precursor cell therapy reverses canine Alzheimer dementia-like syndrome in a proof of concept veterinary trial","volume":"13","author":"Valenzuela M","year":"2022","unstructured":"Valenzuela M, Duncan T, Abey A, et al. Autologous skin-derived neural precursor cell therapy reverses canine Alzheimer dementia-like syndrome in a proof of concept veterinary trial. Stem Cell Res Ther. 2022;13(1):261. doi:10.1186\/s13287-022-02933-w"},{"issue":"1","key":"B58","series-title":"J Intern Med","first-page":"107","article-title":"Physical activity and risk of cognitive decline: a meta-analysis of prospective studies","volume":"269","author":"Sofi F","year":"2011","unstructured":"Sofi F, Valecchi D, Bacci D, et al. Physical activity and risk of cognitive decline: a meta-analysis of prospective studies. J Intern Med. 2011;269(1):107\u2013117. doi:10.1111\/j.1365-2796.2010.02281.x"},{"issue":"2","key":"B59","series-title":"Geroscience","first-page":"645","article-title":"Associations between physical activity and cognitive dysfunction in older companion dogs: results from the Dog Aging Project","volume":"45","author":"Bray EE","year":"2023","unstructured":"Bray EE, Raichlen DA, Forsyth KK, et al. Associations between physical activity and cognitive dysfunction in older companion dogs: results from the Dog Aging Project. Geroscience. 2023;45(2):645\u2013661. doi:10.1007\/s11357-022-00655-8"},{"issue":"1","key":"B60","series-title":"Sci Rep","first-page":"13316","article-title":"Evaluation of cognitive function in the Dog Aging Project: associations with baseline canine characteristics","volume":"12","author":"Yarborough S","year":"2022","unstructured":"Yarborough S, Fitzpatrick A, Schwartz SM; Dog Aging Project Consortium. Evaluation of cognitive function in the Dog Aging Project: associations with baseline canine characteristics. Sci Rep. 2022;12(1):13316. doi:10.1038\/s41598-022-15837-9. Published correction appears in Sci Rep. 2023;13(1):8753. doi:10.1038\/s41598-023-34875-5"},{"issue":"8","key":"B61","series-title":"Heliyon","first-page":"e18443","article-title":"Oral treatment with the all-d-peptide RD2 enhances cognition in aged Beagle dogs - a model of sporadic Alzheimer\u2019s disease","volume":"9","author":"Kutzsche J","year":"2023","unstructured":"Kutzsche J, Schemmert S, Bujnicki T, et al. Oral treatment with the all-d-peptide RD2 enhances cognition in aged Beagle dogs - a model of sporadic Alzheimer\u2019s disease. Heliyon. 2023;9(8):e18443. doi:10.1016\/j.heliyon.2023.e18443"},{"issue":"6","key":"B62","series-title":"Aging Cell","first-page":"e13371","article-title":"Therapeutic efficacy of novel memantine nitrate MN-08 in animal models of Alzheimer\u2019s disease","volume":"20","author":"Wu L","year":"2021","unstructured":"Wu L, Zhou X, Cao Y, et al. Therapeutic efficacy of novel memantine nitrate MN-08 in animal models of Alzheimer\u2019s disease. Aging Cell. 2021;20(6):e13371. doi:10.1111\/acel.13371"},{"issue":"3","key":"B63","series-title":"J Vet Behav","first-page":"118","article-title":"Use of memantine in treatment of canine compulsive disorders","volume":"4","author":"Schneider BM","year":"2009","unstructured":"Schneider BM, Dodman NH, Maranda L. Use of memantine in treatment of canine compulsive disorders. J Vet Behav. 2009;4(3):118\u2013126. doi:10.1016\/j.jveb.2008.10.008"},{"key":"B64","series-title":"Eur J Pharmacol","first-page":"173554","article-title":"Alzheimer\u2019s disease: recent treatment strategies","volume":"887","author":"Vaz M","year":"2020","unstructured":"Vaz M, Silvestre S. Alzheimer\u2019s disease: recent treatment strategies. Eur J Pharmacol. 2020;887:173554. doi:10.1016\/j.ejphar.2020.173554"}],"container-title":["American Journal of Veterinary Research"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/aop\/ajvr.25.02.0053\/ajvr.25.02.0053.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/aop\/ajvr.25.02.0053\/ajvr.25.02.0053.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/aop\/ajvr.25.02.0053\/ajvr.25.02.0053.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T03:47:25Z","timestamp":1745984845000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/aop\/ajvr.25.02.0053\/ajvr.25.02.0053.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":64,"URL":"https:\/\/doi.org\/10.2460\/ajvr.25.02.0053","relation":{},"ISSN":["0002-9645","1943-5681"],"issn-type":[{"value":"0002-9645","type":"print"},{"value":"1943-5681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]}}}